Literature DB >> 22016495

Self-plagiarism.

Bruce A Chabner.   

Abstract

Mesh：

Year:  2011        PMID： 22016495      PMCID： PMC3228062          DOI： 10.1634/theoncologist.2011-0312

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  6 in total

Review 1.  Molecularly targeted therapy in renal cell carcinoma.

Authors:  W Kimryn Rathmell; Tricia M Wright; Brian I Rini
Journal:  Expert Rev Anticancer Ther       Date:  2005-12       Impact factor: 4.512

Review 2.  Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: biology, clinical results and future development.

Authors:  Brian I Rini; Jeffrey A Sosman; Robert J Motzer
Journal:  BJU Int       Date:  2005-08       Impact factor: 5.588

Review 3.  The current role of angiogenesis inhibitors in the treatment of renal cell carcinoma.

Authors:  Toni K Choueiri; Ronald M Bukowski; Brian I Rini
Journal:  Semin Oncol       Date:  2006-10       Impact factor: 4.929

Review 4.  VEGF-targeted therapy in metastatic renal cell carcinoma.

Authors:  Brian I Rini
Journal:  Oncologist       Date:  2005-03

5.  Stanford investigates plagiarism charge.

Authors:  C Norman
Journal:  Science       Date:  1984-04-06       Impact factor: 47.728

Review 6.  Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma.

Authors:  Brian I Rini; Eric J Small
Journal:  J Clin Oncol       Date:  2004-11-08       Impact factor: 44.544
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.